IGM Biosciences (IGMS) Stock Statistics & Valuation Metrics

IGM Biosciences has a market cap or net worth of $87.27M. The enterprise value is $225.70M.

IGM Biosciences has 34,388,420 shares outstanding. The number of shares has decreased by -2.65% in one year.

IGM Biosciences’s return on equity (ROE) is -4.06 and return on invested capital (ROIC) is -88.68%.

The current PE Ratio of IGM Biosciences is -1.89. IGM Biosciences’s PEG ratio is 0.06.

In the last 12 months, IGM Biosciences had revenue of 2.68M and earned -195.79M in profits. Earnings per share was -3.24.

In the last 12 months, operating cash flow was -153.00M and capital expenditures -5.85M, giving a free cash flow of -158.85M billion.

IGM Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

IGM Biosciences upcoming earnings date is May 8, 2025, TBA Not Confirmed.

IGM Biosciences as a current ratio of 5.14, with Debt / Equity ratio of 93.80%

In the past 12 months, IGM Biosciences has paid 0.00 in taxes.

IGM Biosciences EV to EBITDA ratio is -1.86, with an EV/FCF ratio of -2.45.

IGM Biosciences has $183.79M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$138.60M billion.

Gross margin is -66.18%, with operating margin of -7785.74%, and net profit margin of -7308.51%.

The average price target for IGM Biosciences is $1.69, which is 11.43% higher than the current price. The consensus rating is Moderate Sell